Ferric Contrast has been awarded a National Science Foundation STTR Phase II grant for $750,000. The grant will further commercialzation of our iron-based MRI contarst agents.
Ferric Contrast Goes to Washington
Ferric Contrast Selected to Represent American Assocication of Universities and Association of Public Land-Grant Universities at Capitol Hill Event
Ferric Contrast to Exhibit at Bright Buffalo Niagara
Come by our booth May 2 at the historic Hotel Henry and see how we are making MRI imaging safer.
Study Finds Gadolinium in Bone
Canadian Researchers Find Residual MRI Contrast Agent in Tissue
Ferric Contrast, Inc. wins competitive National Science Foundation STTR award to advance R&D on novel MRI contrast agents.
Ferric Contrast wins $50,000 at 2017 FuzeHub Commercialization Competition in Albany
“This funding will help these companies advance their commercialization strategies, which was one of the major objectives of the competition.”
Elena Garuc, executive director